Results 131 to 140 of about 18,010 (199)
Additional file 2 of Genomic and molecular characterisation of a KPC-producing Klebsiella pneumoniae clinical isolate resistant to meropenem-vaborbactam, imipenem-relebactam, and ceftazidime-avibactam
Yu Wan, Joshua L. C. Wong, Julia Sanchez-Garrido, Wen Wen Low, Jane F. Turton, Fabio Morecchiato, Ilaria Baccani, Kirsty Dodgson, Gian Maria Rossolini, Neil Woodford, Gad Frankel, Elita Jauneikaite, Danièle Meunier, Katie L. Hopkins +13 moreopenalex +2 more sourcesAdditional file 3 of Genomic and molecular characterisation of a KPC-producing Klebsiella pneumoniae clinical isolate resistant to meropenem-vaborbactam, imipenem-relebactam, and ceftazidime-avibactam
Yu Wan, Joshua L. C. Wong, Julia Sanchez-Garrido, Wen Wen Low, Jane F. Turton, Fabio Morecchiato, Ilaria Baccani, Kirsty Dodgson, Gian Maria Rossolini, Neil Woodford, Gad Frankel, Elita Jauneikaite, Danièle Meunier, Katie L. Hopkins +13 moreopenalex +2 more sourcesAdditional file 4 of Genomic and molecular characterisation of a KPC-producing Klebsiella pneumoniae clinical isolate resistant to meropenem-vaborbactam, imipenem-relebactam, and ceftazidime-avibactam
Yu Wan, Joshua L. C. Wong, Julia Sanchez-Garrido, Wen Wen Low, Jane F. Turton, Fabio Morecchiato, Ilaria Baccani, Kirsty Dodgson, Gian Maria Rossolini, Neil Woodford, Gad Frankel, Elita Jauneikaite, Danièle Meunier, Katie L. Hopkins +13 moreopenalex +2 more sourcesEffect of meropenem-vaborbactam vs piperacillin-Tazobactam on clinical cure or improvement and microbial eradication in complicated urinary tract infection the TANGO I randomized clinical trial
, 2018 IMPORTANCE Meropenem-vaborbactam is a combination carbapenem/beta-lactamase inhibitor and a potential treatment for severe drug-resistant gram-negative infections.Alexander, E.L., Chorvat, E., Sarychev, Y., Kaye, K.S., Horcajada, J.P., Vazquez, J., Giamarellos-Bourboulis, E.J., Fusaro, K., Sagan, O.S., Dudley, M.N., Bleasdale, S.C., Fedosiuk, E., Stus, V., Metallidis, S., Morgan, E., Bhowmick, T., Zaitsev, V., Stoev, V., Murta, C., Bidair, M., Dragoescu, P.O., Griffith, D., Lomovskaya, O., Loutit, J. +23 morecore +1 more sourceMeropenem-vaborbactam as intrathecal-sparing therapy for the treatment of carbapenem-resistant K. pneumoniae shunt-related ventriculitis: two case reports and review of the literature
Recently, an increase in cases of multidrug-resistant Gram-negative bacteria post-neurosurgical ventriculitis and meningitis is reported. Treating these infections has become challenging due to the limited availability of antibiotics and the need to ...Benedetti, Sara, Tumbarello, Mario, Tarantino, Francesca, Sambo, Margherita, Castellani, Paola, Giuliano, Gabriele +5 morecore +1 more sourceAdditional file 1 of Genomic and molecular characterisation of a KPC-producing Klebsiella pneumoniae clinical isolate resistant to meropenem-vaborbactam, imipenem-relebactam, and ceftazidime-avibactam
Yu Wan, Joshua L. C. Wong, Julia Sanchez-Garrido, Wen Wen Low, Jane F. Turton, Fabio Morecchiato, Ilaria Baccani, Kirsty Dodgson, Gian Maria Rossolini, Neil Woodford, Gad Frankel, Elita Jauneikaite, Danièle Meunier, Katie L. Hopkins +13 moreopenalex +2 more sourcesA molecular analysis of meropenem-vaborbactam non-susceptible KPC-producing Klebsiella pneumoniae.
Steven Marshall, Daniel D Rhoads, Liang Chen, Federico Perez, Robert A Bonomo, Andrea M Hujer, Laura J. Rojas, Kristine M Hujer, Michael R Jacobs, David van Duin, Barry N Kreiswirth, Mohamad Yasmin, Henry F. Chambers, Vance Fowler +13 moreopenalex +1 more source
